Cancer Communications | Home page

Cancer Communications | Home page

Cancer Communications

Affiliated with

• 
• 
• Cancer Communications is affiliated with Chinese Anti-Cancer Association and US Chinese Anti-Cancer Association.

Articles

• Recent
• Most accessed
• Collections

1. Content Type:Original Article

     |  1 November 2018

   Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

   Authors:Qiuyan Chen, Linquan Tang, Na Liu, Feng Han, Ling Guo, Shanshan Guo, Jianwei Wang, Huai Liu, Yanfang Ye, Lu Zhang, Liting Liu, Pan Wang, Yingqin Li, Qingmei He, Xiaoqun Yang, Qingnan Tang…
2. Content Type:Editorial

     |  30 October 2018

   Metabolic features of cancer cells

   Authors:Yugang Wang, Yan Xia and Zhimin Lu
3. Content Type:Original Article

     |  26 October 2018

   DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2

   Authors:Yifan Lian, Jiebin Yang, Yikai Lian, Chuangxing Xiao, Xuezhen Hu and Hongzhi Xu
4. Content Type:Review

     |  26 October 2018

   Nonmetabolic functions of metabolic enzymes in cancer development

   Authors:Sean Lu and Yugang Wang
5. Content Type:Original Article

     |  19 October 2018

   IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

   Authors:Liang Wang, Xi-wen Bi, Yu-jia Zhu, Ying-zhi He, Qiu-yu Lai, Zhong-jun Xia and Qing-qing Cai

Most recent articles RSS

View all articles